Back to 
D.A. Davidson & Co.
D.A. Davidson & Co.
LGND
Showing 0 of 2 quarters
Position history for D.A. Davidson & Co.'s holdings in Ligand Pharmaceuticals Incorporated
No. D.A. Davidson exited its LGND (Ligand Pharmaceuticals) position in Q2 2019. Its Q1 2019 13F listed 3,074 shares worth $386,000. D.A. Davidson already held LGND in its Q1 2019 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.